A Johnson City-based entrepreneur and graduate of Georgia Institute of Technology, better known as Georgia Tech, has been named to the institution’s inaugural “40 Under 40” class.
Arnab Chakraborty, Co-Founder and Chief Technology Officer of Flow MedTech, was selected from a group of more than 250 individuals who were nominated by colleagues, peers, and Georgia Tech faculty in April. After nominations were received, a committee of 26 faculty, staff, and volunteer leaders representing all Georgia Tech colleges scored each nominee using a 25-point rubric.
In announcing the class, the Georgia Tech Alumni Association noted that the institution’s “impact reaches every industry, every part of the globe and every aspect of people’s lives through the work of our esteemed alums. Our first class of ‘40 Under 40’ spans the far reaches of the world, representing a wide range of industries with a diversity of ideas.
The group includes: (1) Chaunté Lowe, a four-time Olympian and breast cancer survivor; (2) Joy Buolamwini, Founder of the Algorithmic Justice League, whose research on algorithmic bias in artificial intelligence (AI) has led to policy and industry changes in addressing AI harms; and (3) Maithili Appalwar, who founded Avana to address the alarming rate of suicides among farmers in Yavatmal, a district in Maharashtra, India.
Chakraborty co-founded Flow MedTech with Christine Hang when both were fellow Georgia Tech Biomedical Engineering students. What began as a senior design project in 2013 for them evolved into a full-fledged start-up that is focused on a key cause of strokes as we described in this 2017 article in teknovation.biz.
Along the way, he has also been very active in various efforts to grow the entrepreneurial ecosystem in what is now frequently referred to as the Appalachian Highlands region. One of those most recent efforts involved the rebranding and expansion of an organization now known as FoundersForge. Chakraborty serves as its Mentorship Ambassador.
When we heard the news about the recognition, we asked the Co-Founder to provide an update on his company’s progress.
“Flow MedTech is a medical device company at the forefront of creating solutions the leading cardiovascular physicians need in the operating room,” Chakraborty said. “In 2017, we conducted international market research where I, along with some of our team, visited Europe and Asia speaking with the top cardiologists to validate the clinical need and our solution internationally. Flow MedTech was also thrilled and very fortunate to be able to help sponsor a free health clinic alongside Remote Area Medical and Global Service Projects in India where we were able to provide free health care to nearly 1,000 individuals over the short span of a few days.”
“In 2018, Flow MedTech became a client company of Cleveland Clinic and the Global Cardiovascular Innovation Center, where we currently have an office,” Chakraborty said. “This is tremendous for us as Cleveland Clinic is the #1 hospital for cardiology and heart surgery. Over the years, Flow MedTech has brought on board valuable team members and expanded our business, scientific, and clinical advisory boards.”
The company has filed a number of patent applications, both in the U.S. and internationally, and several have issued.
Chakraborty added that the company participated in Ballad Health’s Cardiovascular Summit in 2019 as a sponsor where members of the team met with the top cardiologists in the region. Flow MedTech also brought on board two manufacturing partners last year with whom the company is currently working to make and test its technology to ensure that is the safest and most effective solution for the patients and physicians.